Learn about Xofluza and how to find it in stock near you.
Despite what it feels like at the pharmacy counter, Xofluza is not on the FDA's national shortage list. The difficulty in finding it usually comes down to local distribution bottlenecks rather than manufacturing failures.
Unlike Tamiflu, which is produced by multiple generic manufacturers, Xofluza is made solely by Genentech. This single supply chain creates real vulnerability. When flu season peaks, demand often surges faster than individual pharmacies can restock their shelves.
There's another frustrating wrinkle: online inventory systems frequently lag behind reality, showing stock that isn't physically there. Because you must take Xofluza within 48 hours of symptom onset, these "ghost inventory" delays aren't just annoying. They're critical.
If you're struggling to locate a dose in time, Medfinder can help you navigate these local gaps and find a pharmacy with actual stock.
No, Xofluza (baloxavir marboxil) is not a controlled substance. It's an antiviral medication specifically approved for treating acute uncomplicated influenza, and it doesn't fall under the DEA's scheduling system. This means there are no government-imposed legal limits or quotas on how much Xofluza can be manufactured or dispensed each year.
So if you're having trouble finding Xofluza, DEA regulations aren't the culprit. The availability issues you're experiencing usually stem from high demand during severe flu seasons, regional distribution bottlenecks, or specific inventory decisions made by local pharmacies.
As of late 2026, Xofluza is not on the FDA shortage list. Supply remains stable nationwide, meaning any difficulty finding the medication is likely due to local distribution bottlenecks rather than a manufacturing failure. While individual pharmacies may temporarily run out during peak flu season, the overall supply chain is functioning normally.
To improve patient access, Genentech announced major updates in October 2026. They've established partnerships with Amazon Pharmacy, Alto Pharmacy, and Mark Cuban Cost Plus Drug Company to help bypass local inventory issues. Additionally, a new Direct-to-Patient program now offers a $50 cash-pay option and same-day delivery in select markets. These give you faster alternatives if your primary pharmacy is out of stock.
When you're sick and racing against a 48-hour clock, you need a plan that works. Here are three strategies that actually help:
If you're too sick to make a dozen phone calls yourself, that's completely understandable. Medfinder can search pharmacies near you and find one with Xofluza actually in stock, so you can focus on resting and recovering.
While Xofluza isn't on the FDA shortage list for 2026, local supply gaps can still leave you scrambling during peak flu season. Because this antiviral works best when taken within 48 hours of symptom onset, you can't afford to waste time driving between pharmacies while you're sick.
Always call ahead to verify stock before you leave your house. Take advantage of the manufacturer's $35 coupon card or the new $50 cash-pay option to manage the cost. And if you're too ill to handle the search yourself, that's okay. You don't have to do this alone.
Medfinder can locate a pharmacy with Xofluza in stock near you, so you can focus entirely on getting better.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
